Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Cardiomyopathies

phenylmethylsulfonyl fluoride has been researched along with Cardiomyopathies in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rozek, RJ1
Kuo, TH1
Giacomelli, F1
Wiener, J1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Cardiomyopathies

ArticleYear
Proteolytic activities in hypertensive cardiomyopathy of rats.
    Journal of molecular and cellular cardiology, 1983, Volume: 15, Issue:3

    Topics: Animals; Calcium; Cardiomyopathies; Cathepsin D; Cathepsins; Ethylmaleimide; Hydrogen-Ion Concentrat

1983